Literature DB >> 23583004

Breed predispositions in canine mast cell tumour: a single centre experience in the United Kingdom.

James Warland1, Jane Dobson.   

Abstract

Genetic factors play a major role in carcinogenesis. Many breeds have been reported to be predisposed to mast cell tumour (MCT) development using various methods and diverse control populations. A database of 222 dogs with MCT seen at a UK university referral hospital was compared to three control populations, namely, an insured population of UK dogs, registrations with the UK Kennel Club and other dogs seen through the same hospital. Odds ratios were calculated for each breed. Boxers, Labradors, Golden Retrievers and Staffordshire Bull Terriers appeared predisposed to MCT development. English Springer Spaniels, English Cocker Spaniels, German Shepherd Dogs, West Highland White Terriers and Cavalier King Charles Spaniels were underrepresented.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breed; Dog; Incidence; Mast cell tumour

Mesh：

Year:  2013        PMID： 23583004     DOI： 10.1016/j.tvjl.2013.02.017

Source DB:  PubMed          Journal:  Vet J        ISSN： 1090-0233            Impact factor:   2.688


  11 in total

1.  Genomic profiling of canine mast cell tumors identifies DNA copy number aberrations associated with KIT mutations and high histological grade.

Authors:  Hiroyuki Mochizuki; Rachael Thomas; Scott Moroff; Matthew Breen
Journal:  Chromosome Res       Date:  2017-01-05       Impact factor: 5.239

2.  Canine mast cell tumours part I: Clinical and survival outcomes.

Authors:  Vanessa S Tamlin; Cynthia D K Bottema; Lucy Woolford; Elizabeth C Dobson; Allan E Kessell; Anne E Peaston
Journal:  Vet Med Sci       Date:  2022-05-03

3.  Pilot assessment of vascular endothelial growth factor receptors and trafficking pathways in recurrent and metastatic canine subcutaneous mast cell tumours.

Authors:  Lucas Da Silva; Carlos E Fonseca-Alves; Jennifer J Thompson; Robert A Foster; Geoffrey A Wood; Renee L Amorim; Brenda L Coomber
Journal:  Vet Med Sci       Date:  2017-06-30

4.  Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study).

Authors:  Galina V Ilyinskaya; Elena V Mukhina; Alesya V Soboleva; Olga V Matveeva; Peter M Chumakov
Journal:  Front Vet Sci       Date:  2018-06-04

5.  Epidemiological assessment of the risk of canine mast cell tumours based on the Kiupel two-grade malignancy classification.

Authors:  Anna Śmiech; Brygida Ślaska; Wojciech Łopuszyński; Agnieszka Jasik; Diana Bochyńska; Roman Dąbrowski
Journal:  Acta Vet Scand       Date:  2018-11-03       Impact factor: 1.695

6.  Occurrence and Distribution of Canine Cutaneous Mast Cell Tumour Characteristics Among Predisposed Breeds.

Authors:  Anna Śmiech; Wojciech Łopuszyński; Brygida Ślaska; Kamila Bulak; Agnieszka Jasik
Journal:  J Vet Res       Date:  2019-03-22       Impact factor: 1.744

7.  Identification of molecular genetic contributants to canine cutaneous mast cell tumour metastasis by global gene expression analysis.

Authors:  Kelly Bowlt Blacklock; Zeynep Birand; Deborah Biasoli; Elena Fineberg; Sue Murphy; Debs Flack; Joyce Bass; Stefano Di Palma; Laura Blackwood; Jenny McKay; Trevor Whitbread; Richard Fox; Tom Eve; Stuart Beaver; Mike Starkey
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

8.  Analysis of risk factors for canine mast cell tumors based on the Kiupel and Patnaik grading system among dogs with skin tumors.

Authors:  Ana Luísa Martins; Fátima Faria Carvalho; João R Mesquita; Fátima Gärtner; Irina Amorim
Journal:  Open Vet J       Date:  2021-11-11

9.  Sequencing and G-quadruplex folding of the canine proto-oncogene KIT promoter region: might dog be used as a model for human disease?

Authors:  Silvia Da Ros; Eleonora Zorzan; Mery Giantin; Lara Zorro Shahidian; Manlio Palumbo; Mauro Dacasto; Claudia Sissi
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

10.  Mutational Hotspot of TET2, IDH1, IDH2, SRSF2, SF3B1, KRAS, and NRAS from Human Systemic Mastocytosis Are Not Conserved in Canine Mast Cell Tumors.

Authors:  Eleonora Zorzan; Katia Hanssens; Mery Giantin; Mauro Dacasto; Patrice Dubreuil
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.752
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.